Research-Grade Peptides.
Lab-Tested. Shipped Fast.
PXPtides supplies high-purity research compounds to laboratories and independent researchers. Verified by third-party analysis, dispatched the same day.
Best Sellers
Most requested research compounds this season.
Retatrutide (Reta)
Triple agonist (GLP-1 / GIP / glucagon) reference peptide.
Tirzepatide (Tirz)
Dual GIP/GLP-1 receptor agonist analogue.
Semaglutide (Sema)
Long-acting GLP-1 receptor agonist analogue.
Cagrilintide
Long-acting amylin analogue for satiety pathway research.
BPC-157
Synthetic pentadecapeptide studied in tissue research.
TB-500
Synthetic fragment of thymosin beta-4.
Glow Mix
GHK-Cu, BPC-157, and TB-500 research blend.
Why researchers choose PXPtides
We exist to make verified, research-grade peptides accessible — without the markup or the wait. Every batch is independently analyzed and shipped under conditions designed to preserve integrity.
- ≥ 99% purity by HPLCReverse-phase HPLC and mass-spec verification on every lot.
- Cold-chain dispatchTemperature-controlled shipping protects lyophilized integrity.
- Certificates on demandLot-matched COAs available for every order.
Shop All Peptides
Explore our full catalog of third-party tested research compounds.
Retatrutide (Reta)
Triple agonist (GLP-1 / GIP / glucagon) reference peptide.
Tirzepatide (Tirz)
Dual GIP/GLP-1 receptor agonist analogue.
Semaglutide (Sema)
Long-acting GLP-1 receptor agonist analogue.
Cagrilintide
Long-acting amylin analogue for satiety pathway research.
Contact Us
Questions about a product, an order, or a lot certificate? Send us a message and our team will get back to you within one business day.
Email: admin@pxptides.com
Hours: Mon–Fri, 9am–5pm ET
The statements on this website have not been evaluated by the U.S. Food and Drug Administration. The products and information provided by PXPtides are not intended to diagnose, treat, cure, or prevent any disease. Emerald Consortium LLC is a research chemical supplier. We are not a compounding pharmacy or compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor are we an outsourcing facility as defined under Section 503B.